Veru Inc.
Symbol: VERU (NASDAQ)
3.84
▲ (0.92%) 0.035
Company Description:
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
Key Stats
- Today's Open: $3.99
- Today's High: $3.99
- Today's Low: $3.725
- Today's Volume: 77.64K
- Yesterday Close: $3.8
- Yesterday High: $3.8144
- Yesterday Low: $3.7
- Yesterday Volume: 62.09K
- Last Min Volume: 1
- Last Min High: $3.835
- Last Min Low: $3.835
- Last Min VWAP: $3.835
Company Profile
- Name: Veru Inc.
- Website: https://www.verupharma.com
- Listed Date: 1990-06-01
- Location: MIAMI, FL
- Market Status: Active
- CIK Number: 0000863894
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $55.67M
- Round Lot: 100
- Outstanding Shares: 14.65M
- Asset Type: CS
RECENT FILINGS FOR VERU
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-26 | 8-K | View |
| 2025-08-27 | 8-K | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-08-12 | 8-K | View |
| 2025-07-25 | 8-K | View |
| 2025-07-16 | SCHEDULE 13G/A | View |
| 2025-07-15 | DEFA14A | View |
| 2025-06-10 | DEFA14A | View |
| 2025-06-10 | DEF 14A | View |
| 2025-05-09 | PRE 14A | View |
| 2025-05-08 | 4 | View |
| 2025-05-08 | 4 | View |
| 2025-05-08 | 4 | View |
| 2025-05-08 | 4 | View |
| 2025-05-08 | 4 | View |
| 2025-05-08 | 4 | View |
| 2025-05-08 | 4 | View |
| 2025-05-08 | 4 | View |
| 2025-05-08 | 10-Q | View |
Latest News on VERU